KYSE-30 ESCC cells harboring epidermal growth factor receptor (EGFR) overexpression and TP53 mutations [25,26,27] can generate tumors in xenografts of orthotopic and subcutaneous implantation [28,29]. The gene discussed is TP53; the disease is esophageal squamous cell carcinoma.